US-Listed Public Company Profile built from SEC and market records · June 2026

BOSTON SCIENTIFIC CORP (BSX)

$45.58 -0.24% NYSE: BSX · 15-min delayed

MARLBOROUGH, Massachusetts
Public · NYSE: BSX
59,000 employees
Founded 1984

Visit website Follow

$65.8BMarket cap

$20.1BRevenue · FY2025

-$1.3BNet income

59,000Employees

BSXNYSE

1992IPO

About BOSTON SCIENTIFIC CORP

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Founded: 1984
Type: Public · NYSE: BSX
Employees: 59,000
IPO date: May 18, 1992
Headquarters: 300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, Massachusetts 01752-1234
Phone: 508-683-4000
Industry: Medical Devices
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: Y6ZDD9FP4P8JSSJMW954

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Is Boston Scientific Corp an American company? Yes. Boston Scientific Corp is incorporated in Delaware, United States and headquartered in Marlborough, Massachusetts. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Registry IDs

Ticker: BSX NYSE
SEC CIK: 885725
LEI: Y6ZDD9FP4P8JSSJMW954
EIN: 042695240
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Boston Scientific Corp’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/boston-scientific-corp/"><img src="https://americancompanies.com/badge/boston-scientific-corp.svg" alt="Boston Scientific Corp — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow BOSTON SCIENTIFIC CORP and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $20.1B
Net income: -$1.3B
Total assets: $43.7B
Market cap: $65.8B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: BSX

$45.58 -0.24%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$41.58 $104.98

52-week range

Market cap: $65.8B
Shares outstanding: 1.4B
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 18, 1992

Boston Scientific Corp (BSX) Stock Price

Reported a net loss of $1.3B in FY2025.
Trading 57% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

MERIT MEDICAL SYSTEMS INCMMSI

ALIGN TECHNOLOGY INCALGN

ECOLAB INC.ECL

DAVITA INC.DVA

Medtronic plcMDT

AMN HEALTHCARE SERVICES INCAMN

No reviews yet. Be the first to review BOSTON SCIENTIFIC CORP.

Write a review

Newsroom

News about BOSTON SCIENTIFIC CORP

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors Zacks Investment Research · 2026-10-21 · negative Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth Zacks Investment Research · 2026-10-21 · negative Boston Scientific (BSX) Rises Higher Than Market: Key Facts Zacks Investment Research · 2026-10-15 · negative Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance? Zacks Investment Research · 2026-10-14 · neutral Why Boston Scientific (BSX) Outpaced the Stock Market Today Zacks Investment Research · 2026-10-09 · negative China Adult Feeding Tubes and Formula Market Outlook to 2033 - Revenue, Volume, Pricing, and Company Share | Forecast Data Reveals Market Entry and Expansion Opportunities GlobeNewswire Inc. · 2026-10-09 · neutral

News & sentiment via Polygon.io

FAQ

Boston Scientific Corp: frequently asked questions

Is Boston Scientific Corp an American company?

Yes — Boston Scientific Corp is an American company. Boston Scientific Corp is incorporated in Delaware, United States and headquartered in Marlborough, Massachusetts. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Boston Scientific Corp incorporated?

Boston Scientific Corp is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Boston Scientific Corp?

Boston Scientific Corp reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Boston Scientific Corp traded on a US stock exchange?

Yes — Boston Scientific Corp trades under the ticker BSX on the NYSE.

Where is Boston Scientific Corp headquartered?

Boston Scientific Corp is headquartered in Marlborough, Massachusetts, United States.

Is Boston Scientific Corp publicly traded?

Yes — Boston Scientific Corp is a publicly traded company. Its stock trades under the ticker symbol BSX on the NYSE.

What does Boston Scientific Corp do?

Boston Scientific Corp is an American Medical Devices company in the Health & Beauty sector.